Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of INCB054707 in Prurigo Nodularis has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prurigo Nodularis

Drugs mentioned

• INCB054707

Snippet

Sponsor: Incyte Corporation | Conditions: Prurigo Nodularis | Phase 2 | Status: COMPLETED | Results posted: 2024-08-27